The Scientist Logo_white
eBOOK

Clinical Antibody Development: A Journey of Discovery

From identifying targets to testing lead candidates, developing antibodies into clinical therapies is a process full of twists and turns.


Twist_Bioscience_Official_Logo

 

473x300 Laptop on F6F6F6 (1)

From finding appropriate targets to developing the final therapeutic molecules, discovering and developing monoclonal antibodies (mAbs) for biopharma involves a complex set of steps. Luckily, new techniques speed up this process and make it more targeted and cost-effective.

Download this ebook from Twist Biopharma for a comprehensive guide to navigating antibody discovery and development.

  • Target identification and validation
  • Antibody discovery and optimization
  • Antibody production and development
  • Candidate selection for clinical development

 
   

The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com

Privacy Policy

© 1986-2022  The Scientist
 
The Scientist Logo_white

The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.